headquartered in Madrid, is a leading biotechnology company specialized in the design and commercialization of genetic diagnostic tests for Pharma, Biotech, Hospitals and Clinicians all over the world.. Pioneers and experts in the design and use of state-of-the-art Genomics and Transcriptomics platforms and also provides highly specialized R&D Services–such as NGS, RNAseq and DECLs–to companies in the Biopharma Industry and in Academic Research Centers worldwide (US, UK and European Union, primarily). NIMGenetics integrates cutting-edge Genomics technologies with an internally developed pipeline of Bioinformatics tools for data analysis and leverages a large proprietary database.
is to satisfy the constantly increasing global demand for experts in the field of “Next Generation Sequencing” who also have the expertise and capacities to be able to meet the high expectations. The colleagues from “NIMGenetics “who constantly expanding their knowledge, technical equipment and customer relation are supported by “BMC” who in turn contribute their expertise in this segments know and identify in global B2B, B2C business and the needs and requirements of the target clients in order to achieve the desired goals.